|
|
| | Niprofazone Basic information |
| Product Name: | Niprofazone | | Synonyms: | Niprofazone;N-[[(2,3-Dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)(1-methylethyl)amino]methyl]-3-pyridinecarboxamide;N-[[(2,3-Dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)(1-methylethyl)amino]methyl]nicotinamide;RA-101【pharmaceutical】;3-Pyridinecarboxamide, N-[[(2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)(1-methylethyl)amino]methyl]- | | CAS: | 15387-10-7 | | MF: | C21H25N5O2 | | MW: | 379.46 | | EINECS: | | | Product Categories: | | | Mol File: | 15387-10-7.mol |  |
| | Niprofazone Chemical Properties |
| Melting point | 165.5°C | | Boiling point | 507.31°C (rough estimate) | | density | 1.2046 (rough estimate) | | refractive index | 1.7600 (estimate) | | pka | 13.62±0.46(Predicted) | | form | Solid |
| Toxicity | LD50 ipr-rat: 400 mg/kg ARZNAD 20,1024,70 |
| | Niprofazone Usage And Synthesis |
| Safety Profile | Poison by intraperitoneal route.Moderately toxic by ingestion and intraperitoneal routes.When heated to decomposition it emits toxic fumes ofNOx. |
| | Niprofazone Preparation Products And Raw materials |
|